Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Brembilla

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
World Journal of Urology|March 21, 2023
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion?Armando Stabile, Gabriele Sorce, Francesco Barletta, et al.
European Journal of Radiology|August 24, 2019
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterizationGiulia Cristel, Antonio Esposito, Anna Damascelli, et al.
European Journal of Radiology|May 4, 2023
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsyGiorgio Brembilla, Salvatore Lavalle, Tom Parry, et al.
European Journal of Radiology|July 22, 2023
Extraprostatic incidental findings on prostate mpMRI: A pictorial review from the ESUR junior networkAndrea Ponsiglione, Irene Campo, Camilla Sachs, et al.
European Radiology|December 23, 2017
Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissectionGiorgio Brembilla, Paolo Dell'Oglio, Armando Stabile, et al.
European Radiology|May 23, 2024
ESR Essentials: using the right scoring system in prostate MRI-practice recommendations by ESURAndrea Ponsiglione, Giorgio Brembilla, Renato Cuocolo, et al.
La Radiologia Medica|February 21, 2026
Diagnostic performance of the clear cell likelihood score (ccLS) for small renal masses characterization in patients undergoing percutaneous biopsyGiorgio Brembilla, Renato Pennella, Gianluca Siciliano, et al.
European Urology Oncology|August 15, 2019
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted BiopsiesPaolo Dell'Oglio, Armando Stabile, Matteo Soligo, et al.
Plos One|February 24, 2022
The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analysesTeresa Marsden, Neil McCartan, Louise Brown, et al.
The Prostate|December 27, 2023
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancerFrancesco Pellegrino, Armando Stabile, Gabriele Sorce, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
World Journal of Urology|March 21, 2023
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion?Armando Stabile, Gabriele Sorce, Francesco Barletta, et al.
European Journal of Radiology|August 24, 2019
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterizationGiulia Cristel, Antonio Esposito, Anna Damascelli, et al.
European Journal of Radiology|May 4, 2023
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsyGiorgio Brembilla, Salvatore Lavalle, Tom Parry, et al.
European Journal of Radiology|July 22, 2023
Extraprostatic incidental findings on prostate mpMRI: A pictorial review from the ESUR junior networkAndrea Ponsiglione, Irene Campo, Camilla Sachs, et al.
European Radiology|December 23, 2017
Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissectionGiorgio Brembilla, Paolo Dell'Oglio, Armando Stabile, et al.
European Radiology|May 23, 2024
ESR Essentials: using the right scoring system in prostate MRI-practice recommendations by ESURAndrea Ponsiglione, Giorgio Brembilla, Renato Cuocolo, et al.
La Radiologia Medica|February 21, 2026
Diagnostic performance of the clear cell likelihood score (ccLS) for small renal masses characterization in patients undergoing percutaneous biopsyGiorgio Brembilla, Renato Pennella, Gianluca Siciliano, et al.
European Urology Oncology|August 15, 2019
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted BiopsiesPaolo Dell'Oglio, Armando Stabile, Matteo Soligo, et al.
Plos One|February 24, 2022
The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analysesTeresa Marsden, Neil McCartan, Louise Brown, et al.
The Prostate|December 27, 2023
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancerFrancesco Pellegrino, Armando Stabile, Gabriele Sorce, et al.
Pageof 7